Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 3, Pages 373
Publisher
MDPI AG
Online
2019-03-19
DOI
10.3390/jcm8030373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method
- (2018) Na Sun et al. BIOSENSORS & BIOELECTRONICS
- Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
- (2018) Borros Arneth BMC CANCER
- Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer
- (2018) Masahiko Amatatsu et al. CANCER SCIENCE
- Liquid Biopsy in Tumor Genetic Diagnosis
- (2018) Andreas Jung et al. Deutsches Arzteblatt International
- Liquid biopsy and its role in an advanced clinical trial for lung cancer
- (2018) Donald J Johann et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A conduit to metastasis: circulating tumor cell biology
- (2017) Douglas S. Micalizzi et al. GENES & DEVELOPMENT
- Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients
- (2017) Chiara Bedin et al. INTERNATIONAL JOURNAL OF CANCER
- JCES01.10 Serial Quantitative Assessment of Plasma Circulating Tumor DNA by Digital NGS in Patients with Lung Cancer
- (2017) Yue Zhao et al. Journal of Thoracic Oncology
- Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer
- (2017) Suzanne Jenkins et al. Journal of Thoracic Oncology
- Blood-based detection ofRASmutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-basedRAStesting
- (2017) Wolff Schmiegel et al. Molecular Oncology
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
- (2017) Ru Wang et al. Oncotarget
- The dawn of the liquid biopsy in the fight against cancer
- (2017) Irma G. Domínguez-Vigil et al. Oncotarget
- Progress in Exosome Isolation Techniques
- (2017) Pin Li et al. Theranostics
- Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer
- (2017) Mariangela Manicone et al. Journal of Thoracic Disease
- Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society
- (2016) Lynette M. Sholl et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients
- (2016) Song Xu et al. CANCER LETTERS
- Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment
- (2016) Junji Uchida et al. CANCER SCIENCE
- Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin
- (2016) Hans Gamperl et al. CELL BIOLOGY INTERNATIONAL
- Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
- (2016) C. Karlovich et al. CLINICAL CANCER RESEARCH
- Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer
- (2016) Katsutoshi Shoda et al. Gastric Cancer
- Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR
- (2016) Atsuko Ashida et al. International Journal of Clinical Oncology
- Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial
- (2016) Qing Zhou et al. Journal of Hematology & Oncology
- Functional studies on circulating and disseminated tumor cells in carcinoma patients
- (2016) Catherine Alix-Panabières et al. Molecular Oncology
- Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer
- (2016) B. Levy et al. ONCOLOGIST
- Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients
- (2016) Olga E. Bryzgunova et al. PLoS One
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
- (2016) Jacob J. Chabon et al. Nature Communications
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
- (2016) Marzia Del Re et al. Oncotarget
- Technical challenges in the isolation and analysis of circulating tumor cells
- (2016) Emma E. van der Toom et al. Oncotarget
- KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials
- (2015) Min Ying et al. Asian Pacific Journal of Cancer Prevention
- The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
- (2015) Markus Wallwiener et al. BMC CANCER
- Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
- (2015) T. Mok et al. CLINICAL CANCER RESEARCH
- Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients
- (2015) C. P. Paweletz et al. CLINICAL CANCER RESEARCH
- Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective
- (2015) Annette Tognela et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells
- (2015) Jin-xing Wei et al. HEPATOLOGY
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
- (2015) Peiyong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
- (2015) Filip Janku et al. Oncotarget
- The detection of EpCAM+ and EpCAM– circulating tumor cells
- (2015) Sanne de Wit et al. Scientific Reports
- Extracellular Vesicles – Powerful Markers of Cancer EVolution
- (2015) Joana Carvalho et al. Frontiers in Immunology
- Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer
- (2015) Sobuhi Iqbal et al. SpringerPlus
- Label-Free Quantitative Detection of Tumor-Derived Exosomes through Surface Plasmon Resonance Imaging
- (2014) Ling Zhu et al. ANALYTICAL CHEMISTRY
- Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
- (2014) L. De Mattos-Arruda et al. ANNALS OF ONCOLOGY
- Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
- (2014) M. Ignatiadis et al. ANNALS OF ONCOLOGY
- Liquid biopsies in lung cancer: The new ambrosia of researchers
- (2014) Christian Rolfo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
- (2014) Stephen Q Wong et al. BMC Medical Genomics
- Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
- (2014) Dharanija Madhavan et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Double-stranded DNA in exosomes: a novel biomarker in cancer detection
- (2014) Basant Kumar Thakur et al. CELL RESEARCH
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
- (2014) S. Couraud et al. CLINICAL CANCER RESEARCH
- HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study
- (2014) Katsutoshi Shoda et al. Gastric Cancer
- Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA,KRASandBRAFin the plasma
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology
- (2014) Mei He et al. LAB ON A CHIP
- Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes
- (2014) Shailender Singh Kanwar et al. LAB ON A CHIP
- Proteomics Analysis of Cancer Exosomes Using a Novel Modified Aptamer-based Array (SOMAscanTM) Platform
- (2014) Jason Webber et al. MOLECULAR & CELLULAR PROTEOMICS
- Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor
- (2014) Hyungsoon Im et al. NATURE BIOTECHNOLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
- (2014) Lorea Manterola et al. NEURO-ONCOLOGY
- TP53 Mutations in Advanced Colorectal Cancer: The Dark Side of the Moon
- (2014) Filippo Pietrantonio et al. ONCOLOGY
- Human semen contains exosomes with potent anti-HIV-1 activity
- (2014) Marisa N Madison et al. Retrovirology
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
- (2014) D. A. Haber et al. Cancer Discovery
- Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma
- (2014) Hongwei Wang et al. Biomed Research International
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases
- (2013) Anatoliy I. Masyuk et al. JOURNAL OF HEPATOLOGY
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
- (2013) Zhi-Qiang Ling et al. PLoS One
- Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
- (2013) K. C. A. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating tumor cells and DNA as liquid biopsies
- (2013) Ellen Heitzer et al. Genome Medicine
- BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
- (2013) Walter W Chen et al. Molecular Therapy-Nucleic Acids
- Circulating Tumor Cells in Lung Cancer
- (2012) Rachel Young et al. ACTA CYTOLOGICA
- Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models
- (2012) Atsushi Suetsugu et al. ADVANCED DRUG DELIVERY REVIEWS
- Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
- (2012) T. J. N. Hiltermann et al. ANNALS OF ONCOLOGY
- Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
- (2012) K. C. A. Chan et al. CLINICAL CHEMISTRY
- Translational genomics: The challenge of developing cancer biomarkers
- (2012) J. D. Brooks GENOME RESEARCH
- Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer
- (2012) Yi Kang et al. International Journal of Clinical Oncology
- Considerations in the development of circulating tumor cell technology for clinical use
- (2012) David R Parkinson et al. Journal of Translational Medicine
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
- (2011) Benjamin J. Hindson et al. ANALYTICAL CHEMISTRY
- Prediction of Posthepatectomy Recurrence of Hepatocellular Carcinoma by Circulating Cancer Stem Cells
- (2011) Sheung Tat Fan et al. ANNALS OF SURGERY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth
- (2011) Takayuki Kogure et al. HEPATOLOGY
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- A Locked Nucleic Acid Clamp-Mediated PCR Assay for Detection of a p53 Codon 249 Hotspot Mutation in Urine
- (2011) Selena Y. Lin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
- (2011) Cecilia Lässer et al. Journal of Translational Medicine
- Quantitative and sensitive detection of rare mutations using droplet-based microfluidics
- (2011) Deniz Pekin et al. LAB ON A CHIP
- Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
- (2010) Benoit Lefebure et al. ANNALS OF SURGERY
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- (2010) Satoshi Matsusaka et al. CANCER SCIENCE
- Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker
- (2010) Hui Zhou et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients
- (2010) Lecia V. Sequist et al. Journal of Thoracic Oncology
- The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
- (2010) Carlos Camps et al. LUNG CANCER
- Optimizing the yield and utility of circulating cell-free DNA from plasma and serum
- (2009) Xiaoyan Xue et al. CLINICA CHIMICA ACTA
- Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer
- (2009) F. Tanaka et al. CLINICAL CANCER RESEARCH
- MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis
- (2009) Kyoung Un Park et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Exosomes: proteomic insights and diagnostic potential
- (2009) Richard J Simpson et al. Expert Review of Proteomics
- Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
- (2009) Corina Kohler et al. Molecular Cancer
- Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
- (2009) Jens Neumann et al. PATHOLOGY RESEARCH AND PRACTICE
- Plasma DNA Quantification in Lung Cancer Computed Tomography Screening
- (2008) Gabriella Sozzi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Large-Scale Study of MT1–MMP as a Marker for Isolated Tumor Cells in Peripheral Blood and Bone Marrow in Gastric Cancer Cases
- (2008) Koshi Mimori et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
- (2008) Kunihiko Hiraiwa et al. ANNALS OF SURGICAL ONCOLOGY
- Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases
- (2008) Gihan Hosny et al. CANCER LETTERS
- Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
- (2008) Raquel Catarino et al. DNA AND CELL BIOLOGY
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now